DNY59
Stock futures were largely unchanged during Monday’s premarket action ahead of a busy Q2 earnings season with releases from some of the world’s most prominent companies, such as EV giant Tesla (TSLA), Goldman Sachs (GS), Bank of America (BAC), Morgan Stanley (MS), Johnson & Johnson (JNJ), Abbott (ABT), American Airlines (AAL), United Airlines (UAL), IBM (IBM), Netflix (NFLX), Taiwan Semiconductor (TSM), Philip Morris (PM), Blackstone (BX), Alcoa (AA) and Novartis (NVS).
Here are some of Monday’s biggest gainers and losers in premarket trading:
Biggest stock gainers
- BridgeBio Pharma (NASDAQ:BBIO) shares rose over 20% in premarket trading on Monday, as the company’s management team prepares to hold an investor call at 8:00 a.m. ET today to announce topline data from the Phase 3 ATTRibute-CM clinical study in patients with transthyretin amyloid cardiomyopathy (ATTR-CM).
- Shares of Zai Lab (NASDAQ:ZLAB) and argenx (NASDAQ:ARGX) rose after the companies revealed positive topline results from the ADHERE study, which looked at VYVGART Hytrulo (efgartigimod alfa and hyaluronidase-qvfc) in individuals with chronic inflammatory demyelinating polyneuropathy (CIDP). The trial met its primary goal (p=0.000039), suggesting that VYVGART Hytrulo had a considerably decreased probability of recurrence when compared to placebo. ARGX is up 25%, while ZLAB is up 7%.
Biggest stock losers
- Opera (OPRA) stock plunged around 4% after the Norwegian company launched a shelf offering worth up to $300 million. Selling shareholders could offer up to 141.7 million shares in the offering.
